Sandro V Porceddu

6PUBLICATIONS
32CO-AUTHORS
Pacific Peoples cultural determinants of healthCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer diagnosisHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 19, 2026
The impact of dysphagia on carers of people with head and neck cancer: development and preliminary validation of the significant other scale for eating in head and neck cancer (SOSE-H&N).

Rebecca L Packer, Laurelie R Wishart, Bena Brown

|May 30, 2025
Top advances of the year: Developments of immunotherapy in cutaneous squamous cell carcinoma, 2023-2024.

|Feb 27, 2025
A Proteomic Signature for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence.

Christopher C Jackson, Jia Jenny Liu, Howard Y Liu

|Apr 24, 2024
Human papillomavirus associated oropharyngeal cancer now the most common mucosal head and neck cancer in Queensland.

Sandro V Porceddu, Theresa Negrello, Neal Rawson

|Sep 12, 2020
A phase 1, single centre, open label, escalating dose study to assess the safety, tolerability and immunogenicity of a therapeutic human papillomavirus (HPV) DNA vaccine (AMV002) for HPV-associated head and neck cancer (HNC).

J Chandra, W P Woo, N Finlayson

Pageof 1

Frequent Collaborators

2 joint publications

Howard Y Liu

2 joint publications

Rahul Ladwa

2 joint publications

Benedict J Panizza

1 joint publications

Mateus Trinconi Cunha